GlassScriptPhysician profile
Nikolas G Capetanakis
NPI 1184835860
$1,127.64
in general payments reported to CMS, 2019-2025
10 companies · $77.18 in 2025
The $77.18 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $219 · 2021: $237 · 2022: $236 · 2023: $103 · 2024: $78.94 · 2025: $77.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $345.48 | 2020-2025 | Liletta |
| Evofem Biosciences, INC. | $202.67 | 2020-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $128.94 | 2019-2025 | Slynd |
| Allergan, INC. | $128.48 | 2019-2020 | |
| Therapeuticsmd, INC. | $83.54 | 2019-2022 | |
| Coopersurgical, INC. | $82.12 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $64.76 | 2020-2021 | |
| Aspira Women'S Health INC | $33.01 | 2024 | Ova1 |
| Hologic Sales and Service, LLC | $30.95 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $27.69 | 2022-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikolas Capetanakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.